Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Longitudinal Monitoring MRD Based on ctDNA

RecruitingOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

November 20, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

December 30, 2026

Conditions
Hepatocellular Carcinoma Resectable
Interventions
DIAGNOSTIC_TEST

circulating tumor DNA

blood sample and tissue specimen for circulating tumor DNA will be done to patient with hepatocellular carcinoma

Trial Locations (7)

510220

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

Unknown

NOT_YET_RECRUITING

The Sixth Affiliated Hospital of South China University of Technology, Foshan

NOT_YET_RECRUITING

Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou

NOT_YET_RECRUITING

Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou

NOT_YET_RECRUITING

Shunde Hospital of Southern Medical University, Guangzhou

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

NOT_YET_RECRUITING

Yuebei People's Hospital, Shaoguan

All Listed Sponsors
lead

Zhujiang Hospital

OTHER